ClinicalTrials.gg
Active, not recruitingNCT07684677Updated Jul 6, 2026

Effect of Participating in a Study of Causes of Pregnancy Loss on Mental Health Outcomes: A Target Trial Emulation Using the COPL Cohort and Danish National Registries

An interventional study of COPL participation in Pregnancy Loss, Early, Major Depression and Anxiety, sponsored by Amager Hospital. Active, not recruiting at 1 site in Denmark. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-07-06.

Sponsored by Amager Hospital · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Registered 5 years 7 months after the study started (first participant enrolled Nov 2020, registered Jun 2026).
Phase
Not applicable
Study type
Interventional
Enrollment
30,000
Allocation
Randomized
Ages
18 Years and older
Sex
Female
01

Study summary

Pregnancy loss is the most common severe pregnancy complication and is associated with significant mental health sequelae, including depression and anxiety. Standard care in Denmark does not include systematic follow-up or aetiological investigation after pregnancy loss. The Copenhagen Odense Pregnancy Loss (COPL) Cohort offered extensive aetiological investigations, and a dedicated clinical follow-up visit 4-10 weeks post-loss. This is a target trial emulation (TTE) designed to estimate the causal effect of COPL participation on women's mental health outcomes one year after pregnancy loss. We will emulate a target trial comparing (1) enrolment into COPL versus (2) standard pregnancy loss care. The study population comprises women aged ≥18 years with a confirmed intrauterine pregnancy loss (ICD-10: DO020, DO021, DO030-DO034) before 22 weeks' gestation treated at Danish public hospitals between November 2020 and April 2025. The primary outcome is new-onset affective disorder (ICD-10: F32*-F39*), neurotic/stress-related disorder (F41*, F43*, F48*), or dispensing of antidepressant (N06A*), anxiolytic (N05B*), or sedating (N05C*) medication within 12 months of pregnancy loss diagnosis. All data will be sourced from Danish National Registries. The difference-in-differences estimator will serve as the primary analytical approach, complemented by instrumental variable analysis (hospital of treatment as instrument) and regression discontinuity design. Inverse probability of treatment weighting will be used to control for measured confounders. Results will be reported as risk ratios and risk differences with 95% confidence intervals. Sensitivity analyses will include per-protocol estimation and exclusion of women with treatable findings identified in COPL.

02

Conditions studied

  • Pregnancy Loss, Early
  • Major Depression
  • Anxiety
  • Stress (Psychology)
03

In context

Abortion, Spontaneous

221 studies on the registry are indexed under Abortion, Spontaneous; 44 are open to participants now.

This study's planned enrollment of 30,000 is above the median of 150 across 120 interventional studies indexed under Abortion, Spontaneous.

Browse Abortion, Spontaneous studies →

Lead sponsor

Amager Hospital is the lead sponsor of 21 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age above 18 years
  • Born in Denmark
  • Verified intrauterine PL before 22 weeks' gestation treated at a public hospital in Denmark

Exclusion criteria

Exclusion Criteria:

  • Non-visualized PL, ectopic PL
  • Gestational age >22 weeks at loss
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
30,000 participants (estimated)

Study arms

  • Experimental
    COPL participant

    Women with pregnancy loss participating in the COPL Cohort

    Other: COPL participation

  • No intervention
    Controls

    Women not included in the COPL cohort

Interventions

  • OtherCOPL participation

    Participation in the COPL cohort

06

What researchers measure

Primary outcomes

  1. New onset affective or stress-related disorder

    Either ICD-10 F32\*-F39\*, F41\*, F43\*, F48\* registered or prescription of antidepressant, anxiolytic or sedating medication after PL

    Time frame: 12 months after PL

Secondary outcomes

  1. Sick leave

    Total number of sick-leave days

    Time frame: First 12 months after PL

  2. Health care utilization

    Total GP use, referral to psychologist/psychiatrist

    Time frame: 12 months after PL

  3. Time to pregnancy

    Time from time zero to next pregnancy

    Time frame: Up to 12 months

  4. Post-natal mood disorder

    In case of subsequent delivery, prevalence of post-natal mood disorder

    Time frame: Up to 12 months after time zero

07

Study locations

1 site
  • Department of Gynecology-and-Obstetrics
    Hvidovre, Denmark
08

References and documents

Individual participant data

Plan to share: No — It is not permitted

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 6, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07684677
Lead sponsor
Amager Hospital
Responsible party
Astrid Marie Kolte (Doctor, Associate professor, Copenhagen University Hospital, Hvidovre) — Principal investigator
First posted
Jul 6, 2026
Start date
Nov 1, 2020
Primary completion
Apr 11, 2025
Completion
Apr 11, 2027 (estimated)
Last update
Jul 6, 2026

Study contacts

Henriette Svarre Nielsen, Professor
principal investigator · Copenhagen University Hospital, Hvidovre

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Jun 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion